Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review.

Tighe, Sean P; Akhtar, Daud; Iqbal, Umair; Ahmed, Aijaz

Tighe, Sean P; Akhtar, Daud; Iqbal, Umair; Ahmed, Aijaz.

Afiliación

Tighe SP; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Akhtar D; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Iqbal U; Department of Gastroenterology and Hepatology, Geisinger Commonwealth School of Medicine, Danville, PA, USA.
Ahmed A; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.

J Clin Transl Hepatol ; 8(4): 454-458, 2020 Dec 28.

Article en En | MEDLINE | ID: mdl-33447529

Palabras clave

ALD; Chronic liver disease; MAFLD; Pharmacokinetics; Silybum marianum; Silymarin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Clin Transl Hepatol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google